Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients with Structural Heart Disease – Single-Center Outcomes in a Ten Year Period

Background: Ventricular tachycardia (VT) commonly occurs in patients with structural heart disease, either of ischemic or non-ischemic nature.Treatment options include various antiarrhythmic drugs (AADs) and implantable cardioverter-defibrillators (ICDs).When AADs fail, radiofrequency (RF) catheter ablation is a valuable treatment option for patients with recurrent VT. 1 This single-center ten-year retrospective study aimed to assess acute and chronic success rates of RF catheter ablation and to identify predictors of VT recurrence and patient survival.